Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors
about
Chemical probes of endocannabinoid metabolismInhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future AntidepressantsQuantitative LC-MS/MS analysis of arachidonoyl amino acids in mouse brain with treatment of FAAH inhibitorApproximating protein flexibility through dynamic pharmacophore models: application to fatty acid amide hydrolase (FAAH)Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol.Metabolism of endocannabinoids and related N-acylethanolamines: canonical and alternative pathways.Sulfonyl fluoride inhibitors of fatty acid amide hydrolase.The endogenous cannabinoid 2-arachidonoylglycerol is intravenously self-administered by squirrel monkeysOptimization of 1,2,5-thiadiazole carbamates as potent and selective ABHD6 inhibitors.Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([¹¹C]MPPO) Based on α-Ketoheterocyclic Scaffold.Recent advances in the discovery and evaluation of fatty acid amide hydrolase inhibitors.Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids.Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase.Quantum mechanics/molecular mechanics modeling of fatty acid amide hydrolase reactivation distinguishes substrate from irreversible covalent inhibitors.The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2.The endocannabinoid system and emotional processing: pathophysiology and therapeutic potential.
P2860
Q26863202-05FF54B7-BF66-4BD8-BF8B-350066F02382Q28082891-0F324D85-FC5B-4620-9FF3-D2360A41FAE2Q28276570-6BDB1F17-3B87-435D-995E-E1BC80A5084FQ28740837-44183552-3FE6-4991-A389-7F4D3BDF702DQ34165188-D9809346-25F3-4B04-BCF2-D4DB12E5DBB0Q34328745-8D1C4836-1ABD-4A6D-9A01-8FFE485BBAD5Q34452685-88487BA2-1B3A-4D30-B282-001EDD8182C4Q35070299-40F50E9A-75C7-493D-8928-16C2DC4E7F42Q35753542-F62A1DEB-C0D2-4D93-86B8-1A2A8D7648BEQ36926261-6EC38F34-2687-4C01-B6A9-4A1C123E8AB8Q38028659-75458516-FCA7-4AE0-B37A-D469E16CB2E5Q38056395-F025FE9D-15A7-49B2-804F-5E6C17783241Q39768988-25A8343E-D587-452C-8C82-9A4E738FFCC7Q43072779-C7F0458D-78C0-460A-83A4-797FBFDB0325Q50142905-048A89F2-A4F9-46E1-BD53-EA140F332FCBQ50592444-903946F7-FF58-42DA-A6B0-637804475C35
P2860
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors
description
2010 nî lūn-bûn
@nan
2010 թուականին հրատարակուած գիտական յօդուած
@hyw
2010 թվականին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors
@ast
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors
@en
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors
@nl
type
label
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors
@ast
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors
@en
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors
@nl
prefLabel
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors
@ast
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors
@en
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors
@nl
P2093
P1476
Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors
@en
P2093
Anna Minkkilä
Susanna Saario
Tapio Nevalainen
P304
P356
10.2174/156802610791164238
P407
P577
2010-01-01T00:00:00Z